Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

QUEST DIAGNOSTICS

(DGX)
  Report
Real-time Estimate Cboe BZX  -  01:17 2022-10-06 pm EDT
125.80 USD   -1.53%
10/05Quest Diagnostics to Buy Summa Health's Outreach Laboratory Services Business
MT
10/03QUEST DIAGNOSTICS : Ex-dividend day for
FA
09/27Quest Diagnostics to Release Third Quarter 2022 Financial Results on October 20, 2022
PR
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 14 38416 06021 22414 898--
Enterprise Value (EV)1 17 96218 91724 36417 96117 73417 669
P/E ratio 17,0x11,4x11,1x15,0x16,9x15,0x
Yield 1,99%1,88%1,53%2,06%2,17%2,20%
Capitalization / Revenue 1,86x1,70x1,97x1,54x1,63x1,58x
EV / Revenue 2,32x2,00x2,26x1,85x1,94x1,87x
EV / EBITDA 11,6x7,66x8,49x8,85x9,81x9,25x
Price to Book 2,52x2,34x3,19x2,29x2,15x2,00x
Nbr of stocks (in thousands) 134 697134 766122 675116 606--
Reference price (USD) 107119173128128128
Announcement Date 01/30/202002/04/202102/03/2022---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 7 7269 43710 7889 6929 1379 443
EBITDA1 1 5492 4682 8702 0301 8081 909
Operating profit (EBIT)1 1 2202 1072 4621 7211 4881 575
Operating Margin 15,8%22,3%22,8%17,8%16,3%16,7%
Pre-Tax Profit (EBT)1 1 0761 8842 5991 4201 3481 566
Net income1 8581 4311 9951 028909992
Net margin 11,1%15,2%18,5%10,6%9,95%10,5%
EPS2 6,2810,515,68,517,588,54
Dividend per Share2 2,122,242,642,632,772,81
Announcement Date 01/30/202002/04/202102/03/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales1 2 7442 6112 4532 3392 2592 189
EBITDA1 659660515468424431
Operating profit (EBIT)1 553554435395344351
Operating Margin 20,2%21,2%17,7%16,9%15,2%16,1%
Pre-Tax Profit (EBT)1 502452323345317334
Net income1 390355234237188209
Net margin 14,2%13,6%9,54%10,1%8,32%9,55%
EPS2 3,122,921,961,941,581,78
Dividend per Share ------
Announcement Date 02/03/202204/21/202207/21/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 3 5782 8573 1403 0632 8362 771
Net Cash position1 ------
Leverage (Debt / EBITDA) 2,31x1,16x1,09x1,51x1,57x1,45x
Free Cash Flow1 8431 5871 8301 2521 0351 216
ROE (Net Profit / Equities) 16,5%24,6%28,4%17,8%14,7%15,1%
Shareholders' equity1 5 1985 8107 0205 7906 1856 574
ROA (Net Profit / Asset) 7,51%11,4%13,2%8,40%7,30%7,63%
Assets1 11 41712 59015 09112 23812 45812 994
Book Value Per Share2 42,450,854,255,759,563,9
Cash Flow per Share2 9,146,7817,414,913,814,1
Capex1 400418403390392392
Capex / Sales 5,18%4,43%3,74%4,03%4,29%4,15%
Announcement Date 01/30/202002/04/202102/03/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Key data
Capitalization (USD) 14 897 620 121
Net sales (USD) 10 788 000 000
Number of employees 44 500
Sales / Employee (USD) 242 427
Free-Float 71,7%
Free-Float capitalization (USD) 10 675 861 235
Avg. Exchange 20 sessions (USD) 131 784 370
Average Daily Capital Traded 0,88%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA